Summary:
- The article details the paradigm shift in oncology brought about by immunotherapy, which empowers the patient's own immune system to recognize and eliminate malignant cells.
- It highlights the evolution of treatment modalities, including immune checkpoint inhibitors and CAR T-cell therapy, while emphasizing ongoing clinical research aimed at overcoming resistance and expanding efficacy across different cancer types.